Angela Ann Giardino, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 4 | 2022 | 2104 | 0.570 |
Why?
|
Education, Medical, Undergraduate | 2 | 2024 | 1085 | 0.530 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2016 | 542 | 0.460 |
Why?
|
Hemangiosarcoma | 1 | 2016 | 215 | 0.440 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2018 | 1642 | 0.430 |
Why?
|
Students, Medical | 2 | 2024 | 1964 | 0.400 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2012 | 1437 | 0.370 |
Why?
|
Lymph Nodes | 2 | 2014 | 3473 | 0.360 |
Why?
|
Lymphoma | 4 | 2016 | 1900 | 0.360 |
Why?
|
Empyema, Pleural | 1 | 2011 | 62 | 0.360 |
Why?
|
Education, Medical | 1 | 2022 | 1742 | 0.340 |
Why?
|
Menisci, Tibial | 1 | 2012 | 267 | 0.340 |
Why?
|
Diagnostic Imaging | 9 | 2015 | 3538 | 0.330 |
Why?
|
Headache | 1 | 2017 | 1263 | 0.320 |
Why?
|
Abdomen | 1 | 2014 | 1137 | 0.290 |
Why?
|
Tibia | 1 | 2012 | 1076 | 0.260 |
Why?
|
Pleural Neoplasms | 1 | 2011 | 612 | 0.260 |
Why?
|
Medical Oncology | 1 | 2017 | 2350 | 0.240 |
Why?
|
Bone Neoplasms | 3 | 2012 | 2565 | 0.220 |
Why?
|
Immunotherapy | 1 | 2017 | 4755 | 0.180 |
Why?
|
Computer-Assisted Instruction | 1 | 2024 | 366 | 0.180 |
Why?
|
Vincristine | 2 | 2012 | 1040 | 0.160 |
Why?
|
Educational Measurement | 2 | 2024 | 1260 | 0.150 |
Why?
|
Melanoma | 1 | 2017 | 5709 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 10 | 2018 | 20776 | 0.150 |
Why?
|
Positron-Emission Tomography | 7 | 2013 | 6673 | 0.140 |
Why?
|
Oncology Service, Hospital | 1 | 2017 | 57 | 0.140 |
Why?
|
Prednisone | 2 | 2012 | 1567 | 0.140 |
Why?
|
Cyclophosphamide | 2 | 2012 | 2227 | 0.130 |
Why?
|
Doxorubicin | 2 | 2012 | 2234 | 0.120 |
Why?
|
Hematologic Neoplasms | 4 | 2015 | 1907 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2017 | 11886 | 0.110 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2016 | 240 | 0.110 |
Why?
|
Contrast Media | 6 | 2016 | 5334 | 0.100 |
Why?
|
Curriculum | 2 | 2024 | 3782 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2016 | 2044 | 0.100 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2011 | 43 | 0.100 |
Why?
|
Splenic Neoplasms | 1 | 2011 | 97 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21187 | 0.090 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 541 | 0.090 |
Why?
|
Fibromatosis, Aggressive | 1 | 2011 | 125 | 0.090 |
Why?
|
Sacrum | 1 | 2011 | 275 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 565 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2011 | 419 | 0.080 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 249 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2017 | 1842 | 0.080 |
Why?
|
Transplantation Conditioning | 1 | 2016 | 1601 | 0.080 |
Why?
|
Sirolimus | 1 | 2016 | 1540 | 0.080 |
Why?
|
Chordoma | 1 | 2011 | 349 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 9442 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 696 | 0.070 |
Why?
|
Urologic Neoplasms | 1 | 2011 | 318 | 0.070 |
Why?
|
Humans | 30 | 2024 | 768887 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 930 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2012 | 2056 | 0.070 |
Why?
|
Osteosarcoma | 1 | 2011 | 911 | 0.060 |
Why?
|
Lymph Node Excision | 1 | 2011 | 1273 | 0.060 |
Why?
|
Amyloidosis | 1 | 2012 | 879 | 0.060 |
Why?
|
Radiotherapy | 1 | 2011 | 1506 | 0.060 |
Why?
|
Mammography | 3 | 2001 | 2434 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3626 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 957 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1386 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3048 | 0.050 |
Why?
|
Neoplasm Metastasis | 4 | 2016 | 4926 | 0.050 |
Why?
|
Female | 13 | 2017 | 397464 | 0.050 |
Why?
|
Sarcoma | 1 | 2011 | 1806 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 36861 | 0.040 |
Why?
|
Middle Aged | 7 | 2017 | 223740 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2336 | 0.040 |
Why?
|
Neoplasm Staging | 4 | 2016 | 11262 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5716 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11119 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3200 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7057 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4363 | 0.030 |
Why?
|
Aged | 6 | 2016 | 171790 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5864 | 0.030 |
Why?
|
Breast Diseases | 1 | 1998 | 442 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2012 | 65485 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4300 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2001 | 933 | 0.030 |
Why?
|
Learning | 1 | 2024 | 1761 | 0.030 |
Why?
|
Cytarabine | 1 | 2016 | 697 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 1997 | 877 | 0.030 |
Why?
|
Fibromatosis, Abdominal | 1 | 2011 | 21 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2011 | 25 | 0.020 |
Why?
|
Tacrolimus | 1 | 2016 | 750 | 0.020 |
Why?
|
Viscera | 1 | 2012 | 138 | 0.020 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 117 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2017 | 997 | 0.020 |
Why?
|
von Hippel-Lindau Disease | 1 | 2011 | 154 | 0.020 |
Why?
|
Joints | 1 | 2012 | 324 | 0.020 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.020 |
Why?
|
Male | 6 | 2016 | 365249 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2411 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18065 | 0.020 |
Why?
|
Breast | 1 | 1998 | 1976 | 0.020 |
Why?
|
Fluorine Radioisotopes | 1 | 2012 | 424 | 0.020 |
Why?
|
Methotrexate | 1 | 2016 | 1723 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11229 | 0.020 |
Why?
|
Prognosis | 3 | 2016 | 30044 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 947 | 0.020 |
Why?
|
Neurofibromatoses | 1 | 2011 | 303 | 0.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 388 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1447 | 0.020 |
Why?
|
Biopsy | 1 | 1998 | 6805 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6856 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 6991 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2916 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2734 | 0.010 |
Why?
|
Adult | 5 | 2016 | 223818 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 89247 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5707 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5046 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4790 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4448 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 13020 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14751 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 3629 | 0.010 |
Why?
|
Lung | 1 | 2012 | 10097 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20244 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 1998 | 790 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10869 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 1997 | 2533 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13593 | 0.000 |
Why?
|
Brain | 1 | 2012 | 27476 | 0.000 |
Why?
|
Young Adult | 1 | 2011 | 60110 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74971 | 0.000 |
Why?
|
Retrospective Studies | 2 | 2001 | 81892 | 0.000 |
Why?
|
Prospective Studies | 1 | 1998 | 54950 | 0.000 |
Why?
|